Actions for HIV

Email RIS file
Bookmark
Report an Issue

HIV/AIDS Drugs, Patents and the TRIPS Agreement [electronic resource] : Issues and Options

Corporate Author
Library of Congress. Congressional Research Service
Published
[Place of publication not identified] : [publisher not identified], 2001.
Physical Description
27 pages : digital, PDF file
Access Online

Availability

I Want It
I Want It

Finding items...

Summary
Examines current dispute between the research-based pharmaceutical industry and certain foreign governments, patient advocacy groups and generic manufacturers regarding patented HIV/AIDS drugs. Reviews fundamentals of patent protection for pharmaceuticals domestically and abroad, and discusses medications used in treating HIV/AIDS. Describes international controversies regarding patents on HIV/AIDS drugs and the potential consequences of these disputes for entrepreneurial drug companies. Reviews legislative issues and options.
Subject(s)
Related Titles
ProQuest U.S. Congressional Research Digital Collection
Note
Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed July 2010). Reuse except for individual research requires license from ProQuest, LLC.
CRS Report.
AVAILABLE ONLINE TO AUTHORIZED PSU USERS.
Technical Details
System requirements: PDF reader software.
View MARC record | catkey: 10083148